Hemophilia patients share their thoughts on a new Needle-Free option

NCT ID NCT06992076

Recruiting now Knowledge-focused Sponsor: Institute of Hematology & Blood Diseases Hospital, China Source: ClinicalTrials.gov ↗

First seen May 07, 2026 · Last updated May 22, 2026 · Updated 3 times

Summary

This study is a registry that will follow about 100 adults and teens with hemophilia who are already taking marstacimab, a monthly shot under the skin. The main goal is to learn how patients feel about this treatment compared to the standard IV infusions, and to measure how much it affects their daily lives. Researchers will also track bleeding rates and joint health over 6 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOPHILIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Institute of haematology and Blood diseases hospital
RECRUITING

Tianjin, Tianjin Municipality, China

Contact

Contact
The First Affiliated Hospital of Xiamen University
RECRUITING

Xiamen, Fujian, China

Contact

Conditions

Explore the condition pages connected to this study.

HEMOPHILIA